FDA/Center for Research on Complex Generics (CRCG) Workshop on Modeling and Artificial Intelligence (AI) in Generic Drug Development and Product Lifecycle Management: Regulatory Insights and Future Trends

The FDA will host a 2-day hybrid workshop exploring the use of Artificial Intelligence (AI) in generic drug development and product lifecycle management. Featuring insights from global regulatory agencies, industry experts, and academic researchers, the event will highlight how AI can streamline workflows, support quantitative medicine, and improve regulatory compliance.

Attendees will gain perspectives on practical AI applications, emerging modeling approaches, and the evolving regulatory landscape. The program includes expert presentations, interactive Q&A panels, and small group discussions for in-person participants.

Visit the event page for more information.